Oestrogen improves glucose metabolism and insulin signal transduction in HepG2 cells

1. Many clinical studies have suggested a relationship between oestrogen and insulin sensitivity. In the present study, HepG2 cells were divided into four groups: (i) control, incubated with 1 nmol/L insulin; (ii) the HI group, which was incubated with 100 nmol/L insulin to induce insulin resistance; (iii) the E2 group, in which control cells were incubated with 1 nmol/L insulin plus 1 nmol/L oestradiol; and (iv) the HI + E2 group, in which insulin‐resistant cells were incubated with 100 nmol/L insulin + 1 nmol/L oestradiol.

[1]  S. Hilsenbeck,et al.  Enhancement of insulin-like growth factor signaling in human breast cancer: estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo. , 1999, Molecular endocrinology.

[2]  M. Mueckler.  Facilitative glucose transporters. , 1994, European journal of biochemistry.

[3]  J. Leahy,et al.  Glucose-fatty acid cycle to inhibit glucose utilization and oxidation is not operative in fatty acid-cultured islets. , 1999, Diabetes.

[4]  G. Reaven,et al.  Resistance to insulin-mediated glucose disposal as a predictor of cardiovascular disease. , 1998, The Journal of clinical endocrinology and metabolism.

[5]  M. Laakso,et al.  Hyperglycemia and cardiovascular disease in type 2 diabetes. , 1999, Diabetes.

[6]  G. Sesti,et al.  Defects of the insulin receptor substrate (IRS) system in human metabolic disorders , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[7]  R. Studer.  Sexual dimorphism in adrenergic regulation of hepatic glycogenolysis. , 1987, The American journal of physiology.

[8]  J. Leahy,et al.  Fatty acid-induced beta cell hypersensitivity to glucose. Increased phosphofructokinase activity and lowered glucose-6-phosphate content. , 1998, The Journal of clinical investigation.

[9]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[10]  W. Garvey,et al.  Glucose and Insulin Chronically Regulate Insulin Action via Different Mechanisms in BC3H1 Myocytes: Effects on Glucose Transporter Gene Expression , 1992, Diabetes.

[11]  D. Brautigan,et al.  Insulin-stimulated Phosphorylation of the Protein Phosphatase-1 Striated Muscle Glycogen-targeting Subunit and Activation of Glycogen Synthase* , 2000, The Journal of Biological Chemistry.

[12]  M. Soley,et al.  Epidermal growth factor administration decreases liver glycogen and causes mild hyperglycaemia in mice. , 1996, The Biochemical journal.

[13]  L. Wallentin,et al.  Metabolic and hormonal effects of post-menopausal oestrogen replacement treatment. I. Glucose, insulin and human growth hormone levels during oral glucose tolerance tests. , 1977, Acta endocrinologica.

[14]  C. Kahn,et al.  Insulin signalling and the regulation of glucose and lipid metabolism , 2001, Nature.

[15]  I. Godsland,et al.  Effects of oral and transdermal 17beta-estradiol with cyclical oral norethindrone acetate on insulin sensitivity, secretion, and elimination in postmenopausal women. , 2000, Metabolism: clinical and experimental.

[16]  T. Buchanan,et al.  Original ArticlesComparison of Estimates of Insulin Sensitivity in Pre- and Postmenopausal Women Using the Insulin Tolerance Test and the Frequently Sampled Intravenous Glucose Tolerance Test , 1994 .

[17]  J. Connell,et al.  Sex hormones induce insulin resistance in 3T3-L1 adipocytes by reducing cellular content of IRS proteins , 2000, Diabetologia.

[18]  C. Kahn,et al.  Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. , 2000, Molecular cell.

[19]  D. Turnbull,et al.  Decreased insulin responsiveness of glucose uptake in cultured human skeletal muscle cells from insulin-resistant nondiabetic relatives of type 2 diabetic families. , 2000, Diabetes.

[20]  J. Gorski,et al.  Regulation of glucose transporters by estradiol in the immature rat uterus. , 1999, Endocrinology.

[21]  T. Buchanan,et al.  Comparison of estimates of insulin sensitivity in pre- and postmenopausal women using the insulin tolerance test and the frequently sampled intravenous glucose tolerance test. , 1994, Journal of the Society for Gynecologic Investigation.

[22]  W. Cefalu.  The use of hormone replacement therapy in postmenopausal women with type 2 diabetes. , 2001, Journal of women's health & gender-based medicine.

[23]  B. Falkner,et al.  Hyperinsulinism and sex hormones in young adult African Americans. , 1999, Metabolism: clinical and experimental.

[24]  L. Wallentin,et al.  METABOLIC AND HORMONAL EFFECTS OF POST-MENOPAUSAL OESTROGEN REPLACEMENT TREATMENT , 1977 .

[25]  A. Barnett,et al.  HRT in women with diabetes--review of the effects on glucose and lipid metabolism. , 2001, Diabetes research and clinical practice.

[26]  E. Rozengurt,et al.  Multiple control mechanisms underlie initiation of growth in animal cells , 1974, Nature.

[27]  P. Chambon,et al.  Promoter elements of genes coding for proteins and modulation of transcription by estrogens and progesterone. , 1984, Recent progress in hormone research.

[28]  S. Hunter,et al.  Insulin action and insulin resistance: diseases involving defects in insulin receptors, signal transduction, and the glucose transport effector system. , 1998, The American journal of medicine.

[29]  G. Shulman,et al.  Disruption of IRS-2 causes type 2 diabetes in mice , 1998, Nature.

[30]  R. Cannon,et al.  Effects of oestrogens and selective oestrogen receptor modulators on serum lipoproteins and vascular function. , 1998, Current opinion in lipidology.

[31]  H. Reinauer,et al.  Activity of the pyruvate dehydrogenase complex in the mammary gland of normal and diabetic rats , 1976, Diabetologia.

[32]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[33]  R. Lobo,et al.  A possible bimodal effect of estrogen on insulin sensitivity in postmenopausal women and the attenuating effect of added progestin. , 1993, Fertility and sterility.

[34]  S. Mudaliar,et al.  Acquired Defects of Glycogen Synthase Activity in Cultured Human Skeletal Muscle Cells: Influence of High Glucose and Insulin Levels , 1996, Diabetes.

[35]  T. Yagi,et al.  Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1 , 1994, Nature.

[36]  D. Pfaff,et al.  Estrogen and thyroid hormone interaction on regulation of gene expression. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[37]  B. Korsgaard,et al.  A time course study of the effect of repetitive doses of estradiol-17 beta on serum glucose and lipids, liver glycogen and some carbohydrate metabolizing enzymes in liver of male flounder (Platichtys flesus L.). , 1983, Comparative biochemistry and physiology. B, Comparative biochemistry.

[38]  M. Enserink.  Despite Safety Concerns, U.K. Hormone Study to Proceed , 2002, Science.

[39]  R. Chakrabarti,et al.  Demonstration of an insulin‐insensitive storage pool of glucose transporters in rat hepatocytes and HepG2 cells , 1992, Journal of cellular physiology.

[40]  R. Bergman,et al.  Free Fatty Acid as a Link in the Regulation of Hepatic Glucose Output by Peripheral Insulin , 1995, Diabetes.